Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
01 Septiembre 2023 - 6:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that management
will participate in upcoming presentations at the following
investor conferences in September.
- Morgan Stanley 21st Annual Global
Healthcare Conference in New York, NY on Monday, September 11,
2023, at 11:20 a.m. E.T.
- Cantor Global Healthcare Conference
2023 in New York, NY on Wednesday, September 27, 2023, at 1:15 p.m.
E.T.
A live audio webcast of each presentation can also be accessed
via the investors section of the Amicus Therapeutics corporate
website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
diseases. With extraordinary patient focus, Amicus Therapeutics is
committed to advancing and expanding a pipeline of cutting-edge,
first- or best-in-class medicines for rare diseases. For more
information please visit the company’s website at www.amicusrx.com,
and follow on Twitter and LinkedIn.
CONTACT:
Investors:Amicus
TherapeuticsAndrew FaughnanVice President, Investor
Relationsafaughnan@amicusrx.com (609) 662-3809
Media:Amicus TherapeuticsDiana
MooreHead of Global Corporate Communicationsdmoore@amicusrx.com
(609) 662-5079
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Amicus Therapeutics (NASDAQ:FOLD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024